The clinical application of molecular biology in colorectal cancer
- 1 July 1986
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 29 (7) , 475-476
- https://doi.org/10.1007/bf02561595
Abstract
In the last three years, the melding of knowledge of retroviruses, oncogenes, and growth factors has revolutionized the understanding of cellular growth control in both normal and neoplastic cells. Monoclonal antibodies against oncogene products expressed in malignancy provide the clinician with new diagnostic and therapeutic modalities, which can have major applications in the field of colorectal cancer.Keywords
This publication has 7 references indexed in Scilit:
- Anti-peptide antibodies detect oncogene-related proteins in urine.Proceedings of the National Academy of Sciences, 1985
- Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseasesNature, 1984
- A Molecular Basis of CancerScientific American, 1983
- CELLULAR ONCOGENES AND RETROVIRUSESAnnual Review of Biochemistry, 1983
- Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomasCell, 1983
- Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid changeNature, 1982
- Cellular Transforming GenesScience, 1982